Skip to main content

Table 1 Patient characteristics

From: Intra- versus retroplacental hematomas: a retrospective case-control study on pregnancy outcomes

 

Intraplacental hematoma (n = 32)

Retroplacental hematoma (n = 119)

Controls (n = 113)

p

Age (years)a

31 (27;35)

31 (26;34)

31 (27;36)

0.394

Parity (n)a

1 (0;2)

2 (0;2)

2 (0;2)

0.486

Previous PIHb

0

3 (2.5)

0

0.348

Previous IUGRb

1 (3.1)

1 (0.8)

6 (5.3)

0.138

Previous preeclampsiab

1 (3.1)

3 (2.5)

1 (0.9)

0.534

Previous IGDMb

1 (3.1)

4 (3.4)

2 (1.8)

0.653

Previous preterm deliveryb

3 (9.4)

4 (3.4)

7 (6.2)

0.287

Previous IUFDb

4 (12.5)

3 (2.5)

0

0.001

Chorionic villous samplingb

2 (6.3)

0

1 (0.9)

0.039

IGDMb

3 (9.4)

22 (18.5)

26 (23.0)

0.219

Gestational age at diagnosis (completed weeks)a

24 (22–29)

13 (12–21)

<0.001

  1. Data are provided as amedian (interquartile range) or bn (%)
  2. Abbreviations: PIH pregnancy induced hypertension, IUGR intrauterine growth restriction, IGDM insulin-dependent gestational diabetes mellitus, IUFD intrauterine fetal death